Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Emilio Alba Conejo

Showing results (11-20 of 21) with videos related to

Pageof 3
Sort By:
Frontiers in Oncology|August 19, 2024
Role of poly-ADP-ribose polymerase inhibitors after brain progression in platinum-sensitive ovarian cancer: a case report and review of the literatureGonzalo Lendinez-Sanchez, Tamara Diaz-Redondo, Marcos Iglesias-Campos, et al.
Journal of Clinical Medicine|April 5, 2020
Subclinical Arteriosclerosis is Associated With Common Vascular Risk Factors in Long-Term Survivors of Testicular CancerJavier Espíldora-Hernández, Tania Díaz-Antonio, Javier Baena-Espinar, et al.
Clinical Breast Cancer|August 14, 2010
Exemestane and chemotherapy as first-line treatment of metastatic breast cancer: results of a phase II studyJuan de la Haba-Rodriguez, Rosario González Mancha, Gumersindo Pérez Manga, et al.
Clinical Nutrition (Edinburgh, Scotland)|December 10, 2021
The economic cost of not coding disease-related malnutrition: A study in cancer inpatientsIgnacio Ruiz-García, Victoria Contreras-Bolívar, Francisco José Sánchez-Torralvo, et al.
Pain Management Nursing : Official Journal of the American Society of Pain Management Nurses|March 12, 2022
The Benefits of a Therapeutic Exercise and Educational Intervention Program on Central Sensitization Symptoms and Pain-Related Fear Avoidance in Breast Cancer SurvivorsDaniel Gutiérrez-Sánchez, Bella I Pajares-Hachero, Manuel Trinidad-Fernández, et al.
Clinical Breast Cancer|January 16, 2013
The role of immunohistochemistry in breast cancer patients treated with neoadjuvant chemotherapy: an old tool with an enduring prognostic valueAlfonso Sánchez-Muñoz, Yessica Maria Plata-Fernández, Margarita Fernández, et al.
Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico|July 1, 2026
Comparative effectiveness of two alternative dosing strategies of pembrolizumab in metastatic non-small-cell lung cancer in a real-world settingMargarita Garrido-Siles, Jose Carlos Benitez, Elena Alvaro Sanz, et al.
Translational Lung Cancer Research|September 12, 2024
Oncogene-addicted solid tumors and microbiome-lung cancer as a main character: a narrative reviewMora Guardamagna, May-Lucie Meyer, Miguel Ángel Berciano-Guerrero, et al.
Clinical & Developmental Immunology|July 18, 2013
New insights into the role of the immune microenvironment in breast carcinomaLuis de la Cruz-Merino, Antonio Barco-Sánchez, Fernando Henao Carrasco, et al.
European Journal of Cancer (Oxford, England : 1990)|December 10, 2025
Liposomal irinotecan in patients with HER2-negative breast cancer and brain metastases: The PHENOMENAL phase 2 studyManuel Ruiz Borrego, David Páez López-Bravo, Mireia Margelí Vila, et al.
Pageof 3

Showing results (11-20 of 21) with videos related to

Sort By:
Pageof 3
Frontiers in Oncology|August 19, 2024
Role of poly-ADP-ribose polymerase inhibitors after brain progression in platinum-sensitive ovarian cancer: a case report and review of the literatureGonzalo Lendinez-Sanchez, Tamara Diaz-Redondo, Marcos Iglesias-Campos, et al.
Journal of Clinical Medicine|April 5, 2020
Subclinical Arteriosclerosis is Associated With Common Vascular Risk Factors in Long-Term Survivors of Testicular CancerJavier Espíldora-Hernández, Tania Díaz-Antonio, Javier Baena-Espinar, et al.
Clinical Breast Cancer|August 14, 2010
Exemestane and chemotherapy as first-line treatment of metastatic breast cancer: results of a phase II studyJuan de la Haba-Rodriguez, Rosario González Mancha, Gumersindo Pérez Manga, et al.
Clinical Nutrition (Edinburgh, Scotland)|December 10, 2021
The economic cost of not coding disease-related malnutrition: A study in cancer inpatientsIgnacio Ruiz-García, Victoria Contreras-Bolívar, Francisco José Sánchez-Torralvo, et al.
Pain Management Nursing : Official Journal of the American Society of Pain Management Nurses|March 12, 2022
The Benefits of a Therapeutic Exercise and Educational Intervention Program on Central Sensitization Symptoms and Pain-Related Fear Avoidance in Breast Cancer SurvivorsDaniel Gutiérrez-Sánchez, Bella I Pajares-Hachero, Manuel Trinidad-Fernández, et al.
Clinical Breast Cancer|January 16, 2013
The role of immunohistochemistry in breast cancer patients treated with neoadjuvant chemotherapy: an old tool with an enduring prognostic valueAlfonso Sánchez-Muñoz, Yessica Maria Plata-Fernández, Margarita Fernández, et al.
Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico|July 1, 2026
Comparative effectiveness of two alternative dosing strategies of pembrolizumab in metastatic non-small-cell lung cancer in a real-world settingMargarita Garrido-Siles, Jose Carlos Benitez, Elena Alvaro Sanz, et al.
Translational Lung Cancer Research|September 12, 2024
Oncogene-addicted solid tumors and microbiome-lung cancer as a main character: a narrative reviewMora Guardamagna, May-Lucie Meyer, Miguel Ángel Berciano-Guerrero, et al.
Clinical & Developmental Immunology|July 18, 2013
New insights into the role of the immune microenvironment in breast carcinomaLuis de la Cruz-Merino, Antonio Barco-Sánchez, Fernando Henao Carrasco, et al.
European Journal of Cancer (Oxford, England : 1990)|December 10, 2025
Liposomal irinotecan in patients with HER2-negative breast cancer and brain metastases: The PHENOMENAL phase 2 studyManuel Ruiz Borrego, David Páez López-Bravo, Mireia Margelí Vila, et al.
Pageof 3